Optimal antiretroviral concentrations in the CNS are necessary to limit local HIV replication, contribute to preventing the development of HIV-associated neurocognitive disorders, and prevent drug-resistant viral strains in the cerebrospinal fluid (CSF), which have the potential to reinfect the peripheral tissues, including blood, leading to overall treatment failure.9